Literature DB >> 24292897

Blockade of Nav1.8 currents in nociceptive trigeminal neurons contributes to anti-trigeminovascular nociceptive effect of amitriptyline.

Jingyao Liang1, Xiaoyan Liu, Meiyan Pan, Wei Dai, Zhao Dong, Xiaolin Wang, Ruozhuo Liu, Jianquan Zheng, Shengyuan Yu.   

Abstract

Amitriptyline (AMI), a tricyclic antidepressant, has been widely used to prevent migraine attacks and alleviate other various chronic pain, but the underlying mechanism remains unclear. Accumulated evidence suggests that the efficacy of AMI is related to the blockade of voltage-gated sodium channels. The aim of the present study was to investigate the effect of AMI on Na(v)1.8 currents in nociceptive trigeminal neurons and trigeminovascular nociception induced by electrical stimulation of the dura mater surrounding the superior sagittal sinus (SSS) in rats, as in the animal model of vascular headaches such as migraines. Using a whole-cell voltage recording technique, we showed that Na(v)1.8 currents were blocked by AMI in a concentration-dependent manner, with an IC50 value of 6.82 μM in acute isolated trigeminal ganglion neurons of the rats. AMI caused a hyperpolarizing shift in the voltage-dependent activation and steady-state inactivation and significantly blocked in a use-dependent manner and slowed the recovery from the inactivation of Na(v)1.8 currents. In addition, the systemic administration of AMI and A-803467 (a selective Na(v)1.8 channel blocker) potently alleviated the nociceptive behaviors (head flicks and grooming) induced by the electrical stimulation of the dura mater surrounding the SSS. Taken together, our data suggest that Na(v)1.8 currents in nociceptive trigeminal neurons are blocked by AMI through modulating the activation and inactivation kinetics, which may contribute to anti-nociceptive effect of AMI in animal models of migraines.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24292897     DOI: 10.1007/s12017-013-8282-6

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  85 in total

1.  Calcitonin gene-related peptide enhances TTX-resistant sodium currents in cultured dorsal root ganglion neurons from adult rats.

Authors:  Gabriel Natura; Gisela Segond von Banchet; Hans-Georg Schaible
Journal:  Pain       Date:  2005-08       Impact factor: 6.961

2.  Amitriptyline modulates calcium currents and intracellular calcium concentration in mouse trigeminal ganglion neurons.

Authors:  Wenhui Wu; Qing Ye; Wenjuan Wang; LanYun Yan; Qiang Wang; Hang Xiao; Qi Wan
Journal:  Neurosci Lett       Date:  2011-12-01       Impact factor: 3.046

3.  Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients.

Authors:  M-U Jang; J-W Park; H-S Kho; S-C Chung; J-W Chung
Journal:  Oral Dis       Date:  2011-03       Impact factor: 3.511

4.  Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials.

Authors:  Domenico D'Amico
Journal:  Neurol Sci       Date:  2010-06       Impact factor: 3.307

5.  Diversity of expression of the sensory neuron-specific TTX-resistant voltage-gated sodium ion channels SNS and SNS2.

Authors:  F Amaya; I Decosterd; T A Samad; C Plumpton; S Tate; R J Mannion; M Costigan; C J Woolf
Journal:  Mol Cell Neurosci       Date:  2000-04       Impact factor: 4.314

6.  Use-dependent block by lidocaine but not amitriptyline is more pronounced in tetrodotoxin (TTX)-Resistant Nav1.8 than in TTX-sensitive Na+ channels.

Authors:  Andreas Leffler; Anne Reiprich; Durga P Mohapatra; Carla Nau
Journal:  J Pharmacol Exp Ther       Date:  2006-09-27       Impact factor: 4.030

Review 7.  The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.

Authors:  Michael A Rogawski; Wolfgang Löscher
Journal:  Nat Med       Date:  2004-07       Impact factor: 53.440

8.  Perisurgical amitriptyline produces a preventive effect on afferent hypersensitivity following spared nerve injury.

Authors:  Andre Arsenault; Jana Sawynok
Journal:  Pain       Date:  2009-09-11       Impact factor: 6.961

Review 9.  [Mechanisms and genetics of migraine].

Authors:  Anne Ducros
Journal:  CNS Drugs       Date:  2006       Impact factor: 6.497

10.  Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2.

Authors:  Maurizio De Fusco; Roberto Marconi; Laura Silvestri; Luigia Atorino; Luca Rampoldi; Letterio Morgante; Andrea Ballabio; Paolo Aridon; Giorgio Casari
Journal:  Nat Genet       Date:  2003-01-21       Impact factor: 38.330

View more
  11 in total

Review 1.  The use of non-narcotic pain medication in pediatric gastroenterology.

Authors:  Adrian Miranda; Miguel Saps
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

2.  Sigma-1 receptor agonist increases axon outgrowth of hippocampal neurons via voltage-gated calcium ions channels.

Authors:  Dong Li; Shu-Zhuo Zhang; Yu-Hong Yao; Yun Xiang; Xiao-Yun Ma; Xiao-Li Wei; Hai-Tao Yan; Xiao-Yan Liu
Journal:  CNS Neurosci Ther       Date:  2017-10-08       Impact factor: 5.243

3.  Antidepressants inhibit Nav1.3, Nav1.7, and Nav1.8 neuronal voltage-gated sodium channels more potently than Nav1.2 and Nav1.6 channels expressed in Xenopus oocytes.

Authors:  Takafumi Horishita; Nobuyuki Yanagihara; Susumu Ueno; Dan Okura; Reiko Horishita; Tomoko Minami; Yuichi Ogata; Yuka Sudo; Yasuhito Uezono; Takeyoshi Sata; Takashi Kawasaki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-09-14       Impact factor: 3.000

Review 4.  Update of chronic tension-type headache.

Authors:  Shengyuan Yu; Xun Han
Journal:  Curr Pain Headache Rep       Date:  2015-01

5.  Comparison of lidocaine and ropivacaine stellate ganglion blockade in treating upper limb postherpetic neuralgia.

Authors:  Zhouhong Fan; Xin Zheng; Dongbai Li; Haopeng Chen; Lingchao Li
Journal:  Medicine (Baltimore)       Date:  2022-06-10       Impact factor: 1.817

Review 6.  Pain transduction: a pharmacologic perspective.

Authors:  Dan M McEntire; Daniel R Kirkpatrick; Nicholas P Dueck; Mitchell J Kerfeld; Tyler A Smith; Taylor J Nelson; Mark D Reisbig; Devendra K Agrawal
Journal:  Expert Rev Clin Pharmacol       Date:  2016-05-23       Impact factor: 5.045

7.  Depression and anxiety behaviour in a rat model of chronic migraine.

Authors:  Mingjie Zhang; Yufei Liu; Mangsuo Zhao; Wenjing Tang; Xiaolin Wang; Zhao Dong; Shengyuan Yu
Journal:  J Headache Pain       Date:  2017-02-21       Impact factor: 7.277

8.  Key Role of the Membrane Trafficking of Nav1.5 Channel Protein in Antidepressant-Induced Brugada Syndrome.

Authors:  Xi Chen; Chao Zhu; Hao Zhou; Yu Zhang; Zhongqi Cai; Honglin Wu; Xiaomeng Ren; Lei Gao; Jiancheng Zhang; Yang Li
Journal:  Front Physiol       Date:  2018-09-05       Impact factor: 4.566

9.  SDF1-CXCR4 signaling contributes to persistent pain and hypersensitivity via regulating excitability of primary nociceptive neurons: involvement of ERK-dependent Nav1.8 up-regulation.

Authors:  Fei Yang; Wei Sun; Yan Yang; Yan Wang; Chun-Li Li; Han Fu; Xiao-Liang Wang; Fan Yang; Ting He; Jun Chen
Journal:  J Neuroinflammation       Date:  2015-11-24       Impact factor: 8.322

10.  Cognitive impairment in a classical rat model of chronic migraine may be due to alterations in hippocampal synaptic plasticity and N-methyl-D-aspartate receptor subunits.

Authors:  Mingjie Zhang; Yufei Liu; Guanqun Hu; Li Kang; Ye Ran; Min Su; Shengyuan Yu
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.